Search results
Order by most recent / most popular / relevance
Results: 1-1 of 1
Anti-bribery and corruption regulation increasing risks for life sciences companies
- Baker & McKenzie
- -
- Australia
- -
- October 11 2011
Some recent changes to anti-bribery and corruption laws in a number of jurisdictions, together with current high levels of regulator activity, have increased the compliance risks for both companies and individuals
